Elsevier

Elsevier is a Netherlands-based publishing company specializing in scientific, technical, and medical content. It is a part of the RELX Group, formerly known as Reed Elsevier. Its products include journals such as The Lancet and Cell, the ScienceDirect collection of electronic journals, the Trends and Current Opinion series of journals, and the online citation database Scopus. Elsevier's products also include digital tools for research and development (R&D), such as Pathway Studio, QUOSA, and Reaxys. Elsevier publishes approximately 420,000 articles annually in 2,500 journals. Its archives contain seven million publications.

History

Elsevier was founded in 1880 and adopted the name and logo from the Dutch publishing house Elzevir that was an inspiration and has no connection to the contemporary Elsevier. The Elzevir family operated as booksellers and publishers in the Netherlands; the founder, Lodewijk Elzevir (1542–1617), lived in Leiden and established the business in 1580.

Products

Elsevier's products and services include digital tools for research and development (R&D), such as Pathway Studio, QUOSA, and Reaxys. Elsevier publishes approximately 420,000 articles annually in 2,500 journals. Its archives contain seven million publications.

Criticism and controversies

Elsevier has been the subject of numerous controversies related to its business practices, including high prices, support for legislation such as the Research Works Act, and opposition to open access to scholarly information. These controversies have led to protests, including a boycott by academics, which gained significant attention and impact.

See also

• Open access
• Academic publishing
• ScienceDirect
• Scopus
• The Lancet
• Cell

   This article is a publishing-related stub. You can help WikiMD by expanding it!

   This article is a medical stub. You can help WikiMD by expanding it!

• Logo of Elsevier from 2019
  Logo of Elsevier from 2019
• 
  Classic Elsevier logo